Status:
COMPLETED
Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children
Lead Sponsor:
Cairo University
Conditions:
Obesity, Childhood
Eligibility:
All Genders
5-12 years
Phase:
NA
Brief Summary
Evidence shows that omega-3 fatty acids lower blood triglyceride levels, lower blood pressure, enhance insulin sensitivity, and improve heart rate variability (HRV) measures, all of which may be indic...
Detailed Description
This is a two-armed study , the interventional group will be given omega 3 and the control group will be given a placebo and both will be examined for the heart rate variability
Eligibility Criteria
Inclusion
- Children (5-12 years) whose parents or caregivers will agree to be enrolled in the study
- Obese Children (Simple obesity )
- Both males and females
Exclusion
- Patients are known to have cardiac disease
- Patients with associated chronic systemic illness
- Patients with 2ry obesity : (endocrine /metabolic/genetics/drug intake)
- Patients on medications affecting heart rate :structural or arrhythmic
Key Trial Info
Start Date :
April 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 3 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06555705
Start Date
April 3 2024
End Date
September 3 2024
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hoda Atef Abdelsattar Ibrahim
Cairo, Egypt